{"id":622811,"date":"2024-06-02T22:34:08","date_gmt":"2024-06-02T19:34:08","guid":{"rendered":"https:\/\/en.buradabiliyorum.com\/cancer-patients-often-do-better-with-less-intensive-treatment-new-research-finds\/"},"modified":"2024-06-02T22:34:08","modified_gmt":"2024-06-02T19:34:08","slug":"cancer-patients-often-do-better-with-less-intensive-treatment-new-research-finds","status":"publish","type":"post","link":"https:\/\/buradabiliyorum.com\/en\/cancer-patients-often-do-better-with-less-intensive-treatment-new-research-finds\/","title":{"rendered":"#Cancer patients often do better with less intensive treatment, new research finds"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_85 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<label for=\"ez-toc-cssicon-toggle-item-6a4e092269df2\" class=\"ez-toc-cssicon-toggle-label\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #dd3333;color:#dd3333\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #dd3333;color:#dd3333\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/label><input type=\"checkbox\"  id=\"ez-toc-cssicon-toggle-item-6a4e092269df2\" checked aria-label=\"Toggle\" \/><nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/buradabiliyorum.com\/en\/cancer-patients-often-do-better-with-less-intensive-treatment-new-research-finds\/#ESOPHAGEAL_CANCER\" >ESOPHAGEAL CANCER<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/buradabiliyorum.com\/en\/cancer-patients-often-do-better-with-less-intensive-treatment-new-research-finds\/#HODGKIN_LYMPHOMA\" >HODGKIN LYMPHOMA<\/a><\/li><\/ul><\/nav><\/div>\n<pre><code>                                    by Carla K. Johnson                                                                                                                    &lt;\/p&gt;&lt;div&gt;\n<\/code><\/pre>\n<div class=\"article-gallery lightGallery\">\n<div data-thumb=\"https:\/\/scx1.b-cdn.net\/csz\/news\/tmb\/2024\/cancer-patients-often-1.jpg\" data-src=\"https:\/\/scx2.b-cdn.net\/gfx\/news\/hires\/2024\/cancer-patients-often-1.jpg\" data-sub-html=\"In this May 25, 2017 file photo, chemotherapy drugs are administered to a patient at a hospital in Chapel Hill, N.C. Scaling back treatment in some cancers\u2014ovarian, esophageal and Hodgkin lymphoma\u2014can make life easier for patients without compromising outcomes, doctors reported at the American Society of Clinical Oncology annual meeting in early June 2024. Credit: AP Photo\/Gerry Broome, File\">\n<figure class=\"article-img\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/scx1.b-cdn.net\/csz\/news\/800a\/2024\/cancer-patients-often-1.jpg\" alt=\"Cancer patients often do better with less intensive treatment, new research finds\" title=\"In this May 25, 2017 file photo, chemotherapy drugs are administered to a patient at a hospital in Chapel Hill, N.C. Scaling back treatment in some cancers\u2014ovarian, esophageal and Hodgkin lymphoma\u2014can make life easier for patients without compromising outcomes, doctors reported at the American Society of Clinical Oncology annual meeting in early June 2024. Credit: AP Photo\/Gerry Broome, File\" width=\"800\" height=\"530\"\/><figcaption class=\"text-darken text-low-up text-truncate-js text-truncate mt-3\">\n                In this May 25, 2017 file photo, chemotherapy drugs are administered to a patient at a hospital in Chapel Hill, N.C. Scaling back treatment in some cancers\u2014ovarian, esophageal and Hodgkin lymphoma\u2014can make life easier for patients without compromising outcomes, doctors reported at the American Society of Clinical Oncology annual meeting in early June 2024. Credit: AP Photo\/Gerry Broome, File<br \/>\n            <\/figcaption><\/figure>\n<\/div>\n<\/div>\n<p>Scaling back treatment for three kinds of cancer can make life easier for patients without compromising outcomes, doctors reported at the world&#8217;s largest cancer conference.<\/p>\n<p>It&#8217;s part of a long-term trend toward studying whether doing less\u2014less surgery, less chemotherapy or less radiation\u2014can help patients live longer and feel better. The latest studies involved ovarian and esophageal cancer and Hodgkin lymphoma.<\/p>\n<p>Thirty years ago, cancer research was about doing more, not less. In one sobering example, women with advanced breast cancer were pushed to the brink of death with massive doses of chemotherapy and bone marrow transplants. The <a rel=\"nofollow noopener\" target=\"_blank\" href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8127573\/\">approach didn&#8217;t work<\/a> any better than chemotherapy and patients suffered.<\/p>\n<p>Now, in a quest to optimize cancer care, researchers are asking: &#8220;Do we need all that treatment that we have used in the past?&#8221;<\/p>\n<p>It&#8217;s a question, &#8220;that should be asked over and over again,&#8221; said Dr. Tatjana Kolevska, medical director for the Kaiser Permanente National Cancer Excellence Program, who was not involved in the new research.<\/p>\n<p>Often, doing less works because of improved drugs.<\/p>\n<p>&#8220;The good <a href=\"https:\/\/buradabiliyorum.com\/en\/category\/news\/\" data-internallinksmanager029f6b8e52c=\"2\" title=\"News\" target=\"_blank\" rel=\"noopener\">news<\/a> is that cancer treatment is not only becoming more effective, it&#8217;s becoming easier to tolerate and associated with less short-term and long-term complications,&#8221; said Dr. William G. Nelson of Johns Hopkins School of Medicine, who was also not involved in the new research.<\/p>\n<p>Studies demonstrating the trend were discussed over the weekend at an American Society of Clinical Oncology conference in Chicago. Here are the highlights:<\/p>\n<pre><code>                                                                                                    &lt;!-- Google middle Adsense block --&gt;\n\n                                                                                                                                        &lt;h2&gt;OVARIAN CANCER&lt;\/h2&gt;\n<\/code><\/pre>\n<p>French researchers found that it&#8217;s safe to avoid removing lymph nodes that <a href=\"https:\/\/buradabiliyorum.com\/en\/category\/download-scripts-themes-apps\/\" data-internallinksmanager029f6b8e52c=\"9\" title=\"Download Scripts &amp; Themes &amp; Apps\" target=\"_blank\" rel=\"noopener\">app<\/a>ear healthy during surgery for advanced ovarian cancer. The study compared the results for 379 patients\u2014half had their lymph nodes removed and half did not. After nine years, there was no difference in how long the patients lived and those with less-extreme surgery had fewer complications, such as the need for blood transfusions. The research was funded by the National Institute of Cancer in France.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"ESOPHAGEAL_CANCER\"><\/span>ESOPHAGEAL CANCER<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>This German study looked at 438 people with a type of cancer of the esophagus that can be treated with surgery. Half received a common treatment plan that included chemotherapy and surgery on the esophagus, the tube that carries food from the throat to the stomach. Half got another approach that includes radiation too. Both techniques are considered standard. Which one patients get can depend on where they get treatment.<\/p>\n<p>After three years, 57% of those who got chemo and surgery were alive, compared to 51% of those who got chemo, surgery and radiation. The German Research Foundation funded the study.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"HODGKIN_LYMPHOMA\"><\/span>HODGKIN LYMPHOMA<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>A comparison of two chemotherapy regimens for advanced Hodgkin lymphoma found the less intensive treatment was more effective for the blood cancer and caused fewer side effects.<\/p>\n<p>After four years, the less harsh chemo kept the disease in check in 94% of people, compared to 91% of those who had the more intense treatment. The trial included 1,482 people in nine countries\u2014Germany, Austria, Switzerland, the Netherlands, Denmark, Sweden, Norway, Australia and New Zealand\u2014and was funded by Takeda Oncology, the maker of one of the drugs used in the gentler chemo that was studied.<\/p>\n<pre><code>                                                                                                                        &lt;p class=\"article-main__note mt-4\"&gt;\n                                            \u00a9 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.\n                                        &lt;\/p&gt;\n\n                                    &lt;!-- print only --&gt;\n                                    &lt;div class=\"d-none d-print-block\"&gt;\n\n                                             &lt;strong&gt;Citation&lt;\/strong&gt;:\n                                             Cancer patients often do better with less intensive treatment, new research finds (2024, June 2)\n                                             retrieved 2 June 2024\n                                             from https:\/\/medicalxpress.com\/news\/2024-06-cancer-patients-intensive-treatment.html\n\n\n                                        This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no\n                                        part may be reproduced without the written permission. The content is provided for information purposes only.\n\n                                    &lt;\/div&gt;\n\n                                &lt;\/div&gt;&lt;script id=\"<a href=\"https:\/\/buradabiliyorum.com\/en\/category\/social-mediaa\/\" data-internallinksmanager029f6b8e52c=\"1\" title=\"Social Media\" target=\"_blank\" rel=\"noopener\">facebook<\/a>-jssdk\" async=\"\" src=\"https:\/\/connect.facebook.net\/en_US\/sdk.js\"&gt;&lt;\/script&gt;\n<\/code><\/pre>\n<blockquote><p><strong><span style=\"color: #ff6600;\">If you liked the article, do not forget to share it with your friends. Follow us on\u00a0<span style=\"color: #ff0000;\"><a style=\"color: #ff0000;\" href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN63nwsw68G3Aw\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">Google News<\/a><\/span>\u00a0too, click on the star and choose us from your favorites.<\/span><\/strong><\/p><\/blockquote>\n<blockquote>\n<p style=\"text-align: center;\"><strong>If you want to read more Like this articles, you can visit our <span style=\"color: #ff9900;\"><a style=\"color: #ff9900;\" href=\"https:\/\/en.buradabiliyorum.com\/science\/\" target=\"_blank\" rel=\"noopener\">Science category.<\/a><\/span><\/strong><\/p>\n<\/blockquote>\n<p><span style=\"color: black;\"><a style=\"color: #ff9900;\" href=\"https:\/\/medicalxpress.com\/news\/2024-06-cancer-patients-intensive-treatment.html\" target=\"_blank\" rel=\"noopener\">Source<\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>by Carla K. Johnson &lt;\/p&gt;&lt;div&gt; In this May 25, 2017 file photo, chemotherapy drugs are administered to a patient at a hospital in Chapel Hill, N.C. Scaling back treatment in some cancers\u2014ovarian, esophageal and Hodgkin lymphoma\u2014can make life easier for patients without compromising outcomes, doctors reported at the American Society of Clinical Oncology annual meeting&#8230;<\/p>\n","protected":false},"author":1,"featured_media":622812,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/scx2.b-cdn.net\/gfx\/news\/hires\/2024\/cancer-patients-often-1.jpg","fifu_image_alt":"","footnotes":""},"categories":[16],"tags":[],"class_list":["post-622811","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciencee"],"_links":{"self":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/622811","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/comments?post=622811"}],"version-history":[{"count":0,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/622811\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media\/622812"}],"wp:attachment":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media?parent=622811"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/categories?post=622811"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/tags?post=622811"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}